<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="071671-2018"
            EDITION="2018033">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-073266-001</RECEPTION_ID>
      <DELETION_DATE>20180525</DELETION_DATE>
      <FORM_LG_LIST>FR </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>33</NO_OJ>
         <DATE_PUB>20180216</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 033-071671</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:071671-2018:TEXT:FR:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>FR</LG_ORIG>
         <ISO_COUNTRY VALUE="FR"/>
         <IA_URL_GENERAL>https://www.inserm.fr/</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33650000">General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="FR10">Ile-de-France</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="FR107">Val-de-Marne</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="FRL03">Alpes-Maritimes</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">109228</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 221-458692</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180214</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="4">European Union</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Фpaнция</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Общи противовъзпалителни средства за системна употреба, ваксини, антинеопласти и имуномодулатори</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Francie</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva pro systémové užití, očkovací látky, antineoplastika a imunomodulátory</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Frankrig</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektive midler til systemisk brug, vacciner, cytostatike/cytotoxiske midler samt immunmodulerende midler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Frankreich</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva zur systemischen Anwendung, Impfstoffe, Antineoplastika und Immunmodulatoren</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Γαλλία</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Φάρμακα κατά των λοιμώξεων συστηματικής χρήσης, εμβόλια, αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Prantsusmaa</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Üldised infektsioonivastased ained süsteemseks kasutamiseks, vaktsiinid, antineoplastilised ja immuunmoduleerivad ained</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Ranska</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infectieux généraux à usage systémique, vaccins, antinéoplasiques et immunomodulateurs</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Fhrainc, an</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Francuska</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Opća protuupalna sredstva za sustavno liječenje, cjepiva, antineoplastična sredstva i imunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Franciaország</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Általános fertőzésellenes szerek szisztémás használatra, vakcinák, daganatellenes és immunmodulátor szerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Antinfettivi generali per uso sistemico, vaccini, agenti antineoplastici e immunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Prancūzija</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Sistemiškai veikiantys priešinfekciniai vaistai, vakcinos, antinavikiniai vaistai ir imunomoduliatoriai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Vispārēji pretinfekcijas līdzekļi sistēmiskai lietošanai, vakcīnas, antineoplastiskie līdzekļi un imūnmodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Franza</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infettivi ġenerali għall-użu sistematiku, vaċċini, antineoplastika u aġenti immunomodulaturi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Frankrijk</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Algemene infectiewerende middelen voor systemisch gebruik, vaccins, antineoplastica en immunomodulerende middelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Francja</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>França</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infecciosos gerais de uso sistémico, vacinas, antineoplásicos e imunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Franţa</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfecţioase generale pentru uz sistemic, vaccinuri, antineoplazice şi imunomodulatoare</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Francúzsko</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Všeobecné antiinfekčné látky na systémové použitie, očkovacie látky, antineoplastické prostriedky a imunomodulačné činidlá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Antimikotiki za sistemsko zdravljenje, cepiva, zdravila z delovanjem na novotvorbe in imunomodulatorji</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Frankrike</TI_CY>
            <TI_TOWN>Creteil</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva medel för systemiskt bruk, vacciner, cytostatika/cytotoxiska medel, samt immunmodulerande medel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="FR">INST Nal de Santé recherche medicale</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="FR">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>INST Nal de Santé recherche medicale</OFFICIALNAME>
               <ADDRESS>immeuble l'expansion — 3ème étage 9 — 11 rue Georges Enesco</ADDRESS>
               <TOWN>Creteil cedex</TOWN>
               <POSTAL_CODE>94000</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 145172915</PHONE>
               <E_MAIL>estelle.devos@inserm.fr</E_MAIL>
               <n2016:NUTS CODE="FR107"/>
               <URL_GENERAL>https://www.inserm.fr/</URL_GENERAL>
               <URL_BUYER>https://www.marches-publics.gouv.fr/?page=agent.AccueilAgentAuthentifie</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE_OTHER>Etablissement public de santé</CA_TYPE_OTHER>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Prestations pharmaceutiques dans le cadre de l'essai vaccinal EHVA T01 /Anrs Vri05</P>
            </TITLE>
            <REFERENCE_NUMBER>INSERM_PA12_2017-10_AOO</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33650000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Projet portant sur la réalisation de prestations pharmaceutiques dans le cadre de l'essai vaccinal EHVA T01 /Anrs Vri05.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">109228</VAL_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33650000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FR10"/>
               <SHORT_DESCR>
                  <P>Projet portant sur la réalisation de prestations pharmaceutiques dans le cadre de l'essai vaccinal EHVA T01 /Anrs Vri05.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Présentation générale de l'offre et qualité de l'équipe dédiée</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Description des prestations proposées et compréhension des besoins</AC_CRITERION>
                  <AC_WEIGHTING>10</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Modalités d'exécution, moyens logistiques et techniques (équipements locaux de stockage, traçabilité des produits expédiés), démarche qualité liée aux produits et à l'étiquetage</AC_CRITERION>
                  <AC_WEIGHTING>25</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Démarche environnementale</AC_CRITERION>
                  <AC_WEIGHTING>5</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Délai pour la mise en place de la logistique</AC_CRITERION>
                  <AC_WEIGHTING>8</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Délais pour l'étiquetage et le conditionnement d'un lot</AC_CRITERION>
                  <AC_WEIGHTING>6</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_QUALITY>
                  <AC_CRITERION>Délai pour la gestion des expéditions</AC_CRITERION>
                  <AC_WEIGHTING>6</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>Présentation générale du devis</AC_CRITERION>
                  <AC_WEIGHTING>5</AC_WEIGHTING>
               </AC_COST>
               <AC_COST>
                  <AC_CRITERION>Prix global de l'offre</AC_CRITERION>
                  <AC_WEIGHTING>25</AC_WEIGHTING>
               </AC_COST>
               <OPTIONS/>
               <OPTIONS_DESCR>
                  <P>Retour des unités thérapeutiques non utilisées.</P>
               </OPTIONS_DESCR>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <NO_CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 221-458692</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <TITLE>
               <P>Projet EHVA - prestations pharmaceutiques dans le cadre de l'essai vaccinal EHVA T01 ANRS Vri05</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-05</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>1</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Theradis Pharma</OFFICIALNAME>
                     <ADDRESS>41 chemin des Presses</ADDRESS>
                     <TOWN>Cagnes-sur-Mer</TOWN>
                     <POSTAL_CODE>06800</POSTAL_CODE>
                     <COUNTRY VALUE="FR"/>
                     <n2016:NUTS CODE="FRL03"/>
                     <URL>http://www.theradispharma.com/</URL>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">135000</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">109228</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Tribunal administratif de Melun</OFFICIALNAME>
               <ADDRESS>43 avenue du Général-de-Gaulle</ADDRESS>
               <TOWN>Melun</TOWN>
               <POSTAL_CODE>77000</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
            </ADDRESS_REVIEW_BODY>
            <DATE_DISPATCH_NOTICE>2018-02-14</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
